JIANGXI NUCLEAR INDUSTRY REYPHON BIO-CHEMICAL CO LTD
Overview
JIANGXI NUCLEAR INDUSTRY REYPHON BIO-CHEMICAL CO LTD is an active pharmaceutical ingredient (API) supplier with 1 active FDA Type II Drug Master File, covering POLYMYXIN B SULFATE.
Core services & business areas
Active ingredients with DMF or CEP filings
Substances for which JIANGXI NUCLEAR INDUSTRY REYPHON BIO-CHEMICAL CO LTD holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.
API / Drug Master Files
JIANGXI NUCLEAR INDUSTRY REYPHON BIO-CHEMICAL CO LTD holds 1 active (1 total) FDA Type II Drug Master File. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.
- POLYMYXIN B SULFATEActive2017-03-21
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to JIANGXI NUCLEAR INDUSTRY REYPHON BIO-CHEMICAL CO LTD in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.
Is this JIANGXI NUCLEAR INDUSTRY REYPHON BIO-CHEMICAL CO LTD?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Related companies
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.